Patent ID: 8778939

Claim:
A compound of formula (I) or a salt thereof wherein A represents pyridin-2-yl, pyridin-3-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-5-yl, 1,3-oxazol-2-yl, 1H-pyrazol-4-yl or isoxazol-4-yl or a group of formula (a) wherein * represents the point of attachment: wherein when A represents pyridin-3-yl, the pyridinyl ring may optionally be substituted at the 2 position by fluoro, methoxy or CH 2 OH, at the 4 position by methyl or CH 2 OH, or at the 5 position by fluoro; when A represents 1H-pyrazol-4-yl, the pyrazolyl ring may optionally be substituted at the 1 position by methyl, and where A represents isoxazol-4-yl, the isoxazolyl ring may optionally be substituted at the 3 position by methyl or at the 5 position by methyl; R 1 represents halo, haloC 1-3 alkyl, hydroxy, CN, —O(CH 2 ) 2 O(CH 2 ) 2 NH 2 , —CNOH, (O) n (CH 2 ) p R 10 , —(CO)R 10 , R 13 , —(SO 2 )R 13 , (C 1-3 alkylene)(CO) q R 14 , (CH═CH)(CO)R 14 , (C 1-3 alkylene)NHCOR 14 , —O-nitrogen containing monoheterocyclic ring with the proviso that the atom directly attached to the oxygen is not nitrogen, or a nitrogen containing heteroaryl ring, wherein the nitrogen containing monoheterocyclic ring is optionally substituted with one, two or three methyl groups and wherein the nitrogen containing heteroaryl ring is optionally substituted by one two or three groups selected from NH 2 , (C 1-3 alkylene)R 13 , (C 1-3 alkylene)(CO) q R 14 , C 1-3 alkyl and halo; n and q independently represent 0 or 1; p represents 1, 2 or 3; R 2 , R 3 , R 4 , R 5 and R 6 independently represent hydrogen, halo, CN, C 1-3 alkyl or C 1-3 alkoxy; R 7 and R 8 independently represent hydrogen or C 1-2 alkyl; R 9 represents halo, C 1-2 alkyl, C 1-2 alkoxy, —CH 2 CO 2 H or —CONHCH 3 ; R 10 represents hydrogen, C 1-3 alkyl, —NR 11 R 12 , or a nitrogen containing monoheterocyclic ring which ring is optionally substituted with one, two or three methyl groups; R 11 and R 12 are independently selected from hydrogen and C 1-3 alkyl, wherein said C 1-3 alkyl group is optionally substituted with one, two or three halo, hydroxy, cyano or C 1-2 alkoxy groups; R 13 represents —NR 11 R 12 , or a nitrogen containing monoheterocyclic ring which ring is optionally substituted with one, two or three methyl groups and wherein the nitrogen containing monoheterocyclic ring is attached via a nitrogen atom; and R 14 represents hydroxy or C 1-3 alkoxy; with the proviso that the compound of formula (I) is not: 2-[(phenylmethyl)oxy]-N-3-pyridinyl-5-(1-pyrrolidinylsulfonyl)benzamide; 2-{[(3,4-difluorophenyl)methyl]oxy}-5-(1-hydroxyethyl)-N-4-pyridazinylbenzamide; 5-bromo-2-(2-chlorobenzyloxy)-N-(pyridin-3-yl)benzamide; 5-chloro-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide; 5-bromo-N-{3-[(methylamino)carbonyl]phenyl}-2-[(phenylmethyl)oxy]benzamide; or 5-chloro-2-[(2-cyanophenyl)methoxy]-N-phenylbenzamide.